Sign up to save your podcasts
Or
Share Episode 07 - David Mazzo, CEO of Lisata Therapeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 07 - David Mazzo, CEO of Lisata Therapeutics
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
Today, we’re honored to have Dr. David Mazzo with us!
David is the President and CEO of Lisata Therapeutics, a company dedicated to developing innovative therapies for advanced solid tumors and other major diseases. With a career spanning over 40 years in the pharmaceutical industry, we have so much to discuss.
We'll dive into David's journey, the evolution of Lisata
following the merger with Caladrius Biosciences and Cend Therapeutics, and their lead product candidate. He'll also share insights on making tough decisions, fostering a dynamic company culture, and the future of oncology
treatment.
It's an absolute pleasure to welcome Dr. David Mazzo!
Enjoy and stay tuned!
View all episodes
By Max Brennan - Biotech HeadHunterWelcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
Today, we’re honored to have Dr. David Mazzo with us!
David is the President and CEO of Lisata Therapeutics, a company dedicated to developing innovative therapies for advanced solid tumors and other major diseases. With a career spanning over 40 years in the pharmaceutical industry, we have so much to discuss.
We'll dive into David's journey, the evolution of Lisata
following the merger with Caladrius Biosciences and Cend Therapeutics, and their lead product candidate. He'll also share insights on making tough decisions, fostering a dynamic company culture, and the future of oncology
treatment.
It's an absolute pleasure to welcome Dr. David Mazzo!
Enjoy and stay tuned!